Epizyme

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Epizyme and buy or sell other stocks, options, and ETFs commission-free!

About EPZM

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future. 

CEO
Grant C. Bogle, MBA
CEOGrant C. Bogle, MBA
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
Employees

EPZM Key Statistics

Market cap
247.44M
Market cap247.44M
Price-Earnings ratio
-0.85
Price-Earnings ratio-0.85
Dividend yield
Dividend yield
Average volume
4.24M
Average volume4.24M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.80
52 Week high$5.80
52 Week low
$0.411
52 Week low$0.411
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.